We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$141B
AUM Growth
+$12.9B
Cap. Flow
-$2.58B
Cap. Flow %
-1.83%
Top 10 Hldgs %
23.5%
Holding
2,555
New
125
Increased
501
Reduced
893
Closed
65

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$46.9M
2
NET icon
Cloudflare
NET
+$38.2M
3
TXG icon
10x Genomics
TXG
+$33.7M
4
TDOC icon
Teladoc Health
TDOC
+$31.9M
5
PDD icon
Pinduoduo
PDD
+$31.4M

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Healthcare 14.37%
3 Consumer Discretionary 13.81%
4 Communication Services 10.64%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
2401
DELISTED
Catalyst Pharmaceutical
CPRX
$732K ﹤0.01%
219,300
TRC icon
2402
Tejon Ranch
TRC
$443M
$731K ﹤0.01%
50,580
CIVI
2403
DELISTED
Civitas Resources
CIVI
$729K ﹤0.01%
37,700
ATHX
2404
DELISTED
Athersys, Inc. Common Stock
ATHX
$729K ﹤0.01%
16,664
AMTI
2405
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$726K ﹤0.01%
+23,600
New +$748K
HCCI
2406
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$725K ﹤0.01%
34,400
VHC icon
2407
VirnetX Holding Corp
VHC
$65.6M
$717K ﹤0.01%
7,115
RPTX
2408
DELISTED
Repare Therapeutics
RPTX
$713K ﹤0.01%
+20,800
New +$621K
RAPT
2409
DELISTED
RAPT Therapeutics
RAPT
$711K ﹤0.01%
+4,500
New +$978K
STFC
2410
DELISTED
State Auto Financial Corp
STFC
$706K ﹤0.01%
39,800
INBX
2411
DELISTED
Inhibrx, Inc. Common Stock
INBX
$702K ﹤0.01%
+21,300
New +$567K
PRTA icon
2412
Prothena Corp
PRTA
$466M
$695K ﹤0.01%
57,900
CSTE icon
2413
Caesarstone
CSTE
$105M
$693K ﹤0.01%
53,800
DTIL icon
2414
Precision BioSciences
DTIL
$201M
$691K ﹤0.01%
2,760
+83
+3% +$20.3K
XPRO icon
2415
Expro Ltd
XPRO
$2.09B
$690K ﹤0.01%
41,983
OGI
2416
Organigram Holdings
OGI
$179M
$686K ﹤0.01%
129,025
+28,925
+29% +$148K
ARQT icon
2417
Arcutis Biotherapeutics
ARQT
$3.25B
$684K ﹤0.01%
24,300
+3,000
+14% +$73.5K
TXMD icon
2418
TherapeuticsMD
TXMD
$24.1M
$674K ﹤0.01%
11,144
APLT
2419
DELISTED
Applied Therapeutics
APLT
$669K ﹤0.01%
30,400
+1,000
+3% +$20.8K
CUE icon
2420
Cue Biopharma
CUE
$132M
$668K ﹤0.01%
1,780
+60
+3% +$24K
SSTI icon
2421
SoundThinking
SSTI
$109M
$667K ﹤0.01%
17,700
PASG icon
2422
Passage Bio
PASG
$14.8M
$657K ﹤0.01%
1,285
-250
-16% -$100K
ANIP icon
2423
ANI Pharmaceuticals
ANIP
$1.72B
$650K ﹤0.01%
22,400
LFCR icon
2424
Lifecore Biomedical
LFCR
$179M
$650K ﹤0.01%
59,900
CIA icon
2425
Citizens
CIA
$198M
$646K ﹤0.01%
112,700
+6,500
+6% +$39.1K

Similar funds

Swiss National Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Swiss National Bank held 2,555 positions worth $141B, up 10% from $128B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Swiss National Bank's Q4 2020 filing shows 125 new, 501 increased, 893 reduced and 65 closed positions. Its largest new stake was Cloudflare: 582,300 shares worth $44.2M. The largest sale was Apple, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q4 2020 buy was Cloudflare: 582,300 shares worth $44.2M.
  • Swiss National Bank added most to Viatris in Q4 2020, an estimated $46.9M increase.
  • Swiss National Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $349M.
  • Swiss National Bank fully exited Immunomedics Inc in Q4 2020, selling an estimated $37.8M.
  • Swiss National Bank's ten largest holdings make up 24% of its $141B portfolio in Q4 2020.
  • Swiss National Bank opened 125 new positions and closed 65 in Q4 2020.
  • Swiss National Bank's portfolio value rose 10% quarter-over-quarter to $141B.

Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.